Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Cancer. 2012 Jan 17;118(17):4244–4252. doi: 10.1002/cncr.27382

Table 5.

Adverse Events Reported as Definitely, Probably, or Possibly Related to Treatment

ALTENS
(N=47)

Grade
Category 1 2 3 4 5

Gastrointestinal 2 3 0 0 0
Pain 1 0 0 0 0

Worst non-hematologic 3 3 0 0 0
(6%) (6%) (0%) (0%) (0%)

Worst overall 3 3 0 0 0
(6%) (6%) (0%) (0%) (0%)

Adverse events were graded with CTCAE version 3.0